{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:01:38Z","timestamp":1784764898050,"version":"3.55.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Mediastinal lymph-node dissection (MLND) is recommended for resectable non-small-cell lung cancer (NSCLC); however, its prognostic impact remains controversial. We evaluated whether MLND improves prognosis in patients with radiologically solid-dominant clinical stage I NSCLC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed 2212 patients who underwent lobectomy for solid-dominant clinical stage I NSCLC between 2010 and 2022. Prognosis and local control were compared between the MLND and non-MLND groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The MLND and non-MLND groups included 1912 and 300 patients, respectively. After propensity score matching, 5-year overall survival did not show a statistically significant difference between the groups (85.3% vs 79.3%, P\u2009=\u2009.089). MLND identified occult pN2 metastasis in 7.3% (138\/1912) of patients. Notably, 3.6% (68\/1912) of the entire MLND cohort had pN2 disease yet remained recurrence-free. Furthermore, the MLND group demonstrated significantly lower mediastinal lymph-node recurrence than the non-MLND group (P\u2009=\u2009.017). Among patients with pN2 disease in the MLND group, those with recurrence (n\u2009=\u200970) had a higher incidence of intrapulmonary metastases (P\u2009=\u2009.042), a higher number of mediastinal lymph-node metastases (P\u2009=\u2009.002), and a lower rate of skip-N2 involvement (P\u2009=\u2009.031).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Mediastinal lymph-node dissection provides superior local control by reducing mediastinal recurrences and enables accurate pathological staging. While this advantage guides appropriate adjuvant therapy selection, the direct impact of MLND on overall survival remains uncertain. Its true survival benefit should be evaluated in future prospective randomized trials.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/icvts\/ivag189","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:22:49Z","timestamp":1784546569000},"source":"Crossref","is-referenced-by-count":0,"title":["Local Control by Mediastinal Lymph-Node Dissection in Stage I Non-Small-Cell Lung Cancer"],"prefix":"10.1093","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0913-2694","authenticated-orcid":false,"given":"Shunsuke","family":"Morita","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Hiroshima University , Hiroshima, 734-8551,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9993-8928","authenticated-orcid":false,"given":"Takahiro","family":"Mimae","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Hiroshima University , Hiroshima, 734-8551,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokyo Medical University , Tokyo, 160-0023,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Nagashima","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kanagawa Cancer Center , Yokohama, 241-8515,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1966-1709","authenticated-orcid":false,"given":"Norifumi","family":"Tsubokawa","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Hiroshima University , Hiroshima, 734-8551,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Miyata","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Hiroshima University , Hiroshima, 734-8551,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0983-6093","authenticated-orcid":false,"given":"Hiroyuki","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Kanagawa Cancer Center , Yokohama, 241-8515,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Surgery, Tokyo Medical University , Tokyo, 160-0023,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morihito","family":"Okada","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Hiroshima University , Hiroshima, 734-8551,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"2026072219121218600_ivag189-B1","first-page":"ivae020","article-title":"Spirited discussion: lymph node count versus nodal station count","volume":"38","author":"D\u2019Ambrosio","year":"2024","journal-title":"Interdiscip CardioVasc Thorac Surg"},{"key":"2026072219121218600_ivag189-B2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00000658-199801000-00020","article-title":"Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small cell lung cancer: results of a prospective randomized trial","volume":"227","author":"Izbicki","year":"1998","journal-title":"Ann Surg"},{"key":"2026072219121218600_ivag189-B3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s002689900384","article-title":"Systematic lymph node dissection for clinically diagnosed peripheral non-small-cell lung cancer less than 2","volume":"22","author":"Sugi","year":"1998","journal-title":"World J Surg"},{"key":"2026072219121218600_ivag189-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-5002(01)00445-7","article-title":"A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer","volume":"36","author":"Wu","year":"2002","journal-title":"Lung Cancer"},{"key":"2026072219121218600_ivag189-B5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jtcvs.2010.11.008","article-title":"Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial","volume":"141","author":"Darling","year":"2011","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026072219121218600_ivag189-B6","doi-asserted-by":"crossref","first-page":"e109979","DOI":"10.1371\/journal.pone.0109979","article-title":"Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"key":"2026072219121218600_ivag189-B7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/ejcts\/ezw083","article-title":"Lymphadenectomy for clinical early-stage non-small-cell lung cancer: a systematic review and meta-analysis","volume":"50","author":"Meng","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026072219121218600_ivag189-B8","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1093\/ejcts\/ezw439","article-title":"Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small-cell lung cancer: a systematic review of randomized trials and a meta-analysis","volume":"51","author":"Mokhles","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"2026072219121218600_ivag189-B9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/JTO.0b013e31821038ab","article-title":"A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201)","volume":"6","author":"Suzuki","year":"2011","journal-title":"J Thorac Oncol"},{"key":"2026072219121218600_ivag189-B10","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.athoracsur.2024.03.013","article-title":"Omitting lymph node dissection for small ground-glass opacity-dominant tumors","volume":"119","author":"Mimae","year":"2025","journal-title":"Ann Thorac Surg"},{"key":"2026072219121218600_ivag189-B11","first-page":"ivad152","article-title":"Oncologic outcomes of segmentectomy versus lobectomy for clinical T1c radiological pure-solid non-small-cell lung cancer","volume":"37","author":"Hattori","year":"2023","journal-title":"Interdiscip CardioVasc Thorac Surg"},{"key":"2026072219121218600_ivag189-B12","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.jtho.2016.06.028","article-title":"The IASLC lung cancer staging project: methodology and validation used in the development of proposals for revision of the stage classification of NSCLC in the forthcoming (eighth) edition of the TNM classification of lung cancer","volume":"11","author":"Detterbeck","year":"2016","journal-title":"J Thorac Oncol"},{"key":"2026072219121218600_ivag189-B13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jtho.2015.09.009","article-title":"The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer","volume":"11","author":"Goldstraw","year":"2016","journal-title":"J Thorac Oncol"},{"key":"2026072219121218600_ivag189-B14","first-page":"ivae098","article-title":"A clinical nomogram for predicting occult lymph node metastasis in patients with non-small-cell lung cancer \u22642","volume":"39","author":"Ai","year":"2024","journal-title":"Interdiscip CardioVasc Thorac Surg"},{"key":"2026072219121218600_ivag189-B15","first-page":"ivaf151","article-title":"Surgical audience focused on multimodality treatment for lung cancer","volume":"40","author":"Ogliari","year":"2025","journal-title":"Interdiscip CardioVasc Thorac Surg"},{"key":"2026072219121218600_ivag189-B16","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0140-6736(21)02333-3","article-title":"Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802\/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial","volume":"399","author":"Saji","year":"2022","journal-title":"Lancet"},{"key":"2026072219121218600_ivag189-B17","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.jtcvs.2023.11.023","article-title":"Lymph node dissection in small peripheral lung cancer: supplemental analysis of JCOG0802\/WJOG4607L","volume":"168","author":"Maniwa","year":"2024","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026072219121218600_ivag189-B18","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.jtcvs.2024.09.003","article-title":"Mediastinal lymph node dissection in segmentectomy for peripheral c-stage IA (\u22642","volume":"169","author":"Adachi","year":"2025","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2026072219121218600_ivag189-B19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.jtcvs.2023.06.007","article-title":"Tumor distance from the mediastinum predicts N2 upstaging in clinical stage I lower-lobe non-small cell lung cancer","volume":"167","author":"Kawamoto","year":"2024","journal-title":"J Thorac Cardiovasc Surg"}],"container-title":["Interdisciplinary CardioVascular and Thoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/icvts\/advance-article-pdf\/doi\/10.1093\/icvts\/ivag189\/69696595\/ivag189.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/41\/7\/ivag189\/69696595\/ivag189.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/icvts\/article-pdf\/41\/7\/ivag189\/69696595\/ivag189.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:12:27Z","timestamp":1784761947000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/icvts\/article\/doi\/10.1093\/icvts\/ivag189\/8739198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":19,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/icvts\/ivag189","relation":{},"ISSN":["2753-670X"],"issn-type":[{"value":"2753-670X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,7,1]]},"article-number":"ivag189"}}